Your browser doesn't support javascript.
loading
The New Zealand drug harms ranking study: A multi-criteria decision analysis.
Crossin, Rose; Cleland, Lana; Wilkins, Chris; Rychert, Marta; Adamson, Simon; Potiki, Tuari; Pomerleau, Adam C; MacDonald, Blair; Faletanoai, Dwaine; Hutton, Fiona; Noller, Geoff; Lambie, Ian; Sheridan, Jane L; George, Jason; Mercier, Kali; Maynard, Kristen; Leonard, Louise; Walsh, Patricia; Ponton, Rhys; Bagshaw, Sue; Muthukumaraswamy, Suresh; McIntosh, Tracey; Poot, Edward; Gordon, Paul; Sharry, Patrick; Nutt, David; Boden, Joseph.
Afiliação
  • Crossin R; Department of Population Health, University of Otago, Christchurch, New Zealand.
  • Cleland L; Department of Population Health, University of Otago, Christchurch, New Zealand.
  • Wilkins C; Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.
  • Rychert M; SHORE & Whariki Research Centre, College of Health, Massey University, Auckland, New Zealand.
  • Adamson S; SHORE & Whariki Research Centre, College of Health, Massey University, Auckland, New Zealand.
  • Potiki T; Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.
  • Pomerleau AC; Office of Maori Development, University of Otago, Dunedin, New Zealand.
  • MacDonald B; National Poisons Centre, Division of Health Sciences, University of Otago, Dunedin, New Zealand.
  • Faletanoai D; National Drug Intelligence Bureau, New Zealand Police, Wellington, New Zealand.
  • Hutton F; Pacific Mental Health and Addictions Services (Takanga a Fohe), Waitemata District Health Board, Takapuna, New Zealand.
  • Noller G; Institute of Criminology, Victoria University of Wellington, Wellington, New Zealand.
  • Lambie I; Department of General Practice and Rural Health, University of Otago, Dunedin, New Zealand.
  • Sheridan JL; New Zealand Needle Exchange Programme, National Office, Christchurch, New Zealand.
  • George J; Department of Psychology, University of Auckland, Auckland, New Zealand.
  • Mercier K; School of Population Health, University of Auckland, Auckland, New Zealand.
  • Maynard K; New Zealand Needle Exchange Programme, National Office, Christchurch, New Zealand.
  • Leonard L; New Zealand Drug Foundation, Wellington, New Zealand.
  • Walsh P; Rongowhakaata.
  • Ponton R; Ngati Porou.
  • Bagshaw S; Ngati Kahungunu ki Wairoa.
  • Muthukumaraswamy S; Ruapani.
  • McIntosh T; Community and Other Drug Service, Waikato District Health Board, Waikato, New Zealand.
  • Poot E; New Zealand Drug Foundation, Wellington, New Zealand.
  • Gordon P; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Sharry P; Department of Paediatrics, University of Otago, Christchurch, New Zealand.
  • Nutt D; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Boden J; School of Maori Studies and Pacific Studies, Faculty of Arts, University of Auckland, Auckland, New Zealand.
J Psychopharmacol ; 37(9): 891-903, 2023 09.
Article em En | MEDLINE | ID: mdl-37353972
ABSTRACT

AIMS:

The harms arising from psychoactive drug use are complex, and harm reduction strategies should be informed by a detailed understanding of the extent and nature of that harm. Drug harm is also context specific, and so any comprehensive assessment of drug harm should be relevant to the characteristics of the population in question. This study aimed to evaluate and rank drug harms within Aotearoa New Zealand using a multi-criteria decision analysis (MCDA) framework, and to separately consider harm within the total population, and among youth.

METHODS:

Two facilitated workshops involved the separate ranking of harm for the total population, and then for youth aged 12-17, by two expert panels. In the total population workshop, 23 drugs were scored against 17 harm criteria, and those criteria were then evaluated using a swing weighting process. Scoring and weighting were subsequently updated during the youth-specific workshop. All results were recorded and analysed using specialised MCDA software.

RESULTS:

When considering overall harm, the MCDA modelling results indicated that alcohol, methamphetamine and synthetic cannabinoids were the most harmful to both the overall population and the youth, followed by tobacco in the total population. Alcohol remained the most harmful drug for the total population when separately considering harm to those who use it, and harm to others.

CONCLUSIONS:

The results provide detailed and context-specific insight into the harm associated with psychoactive drugs use within Aotearoa New Zealand. The findings also demonstrate the value of separately considering harm for different countries, and for different population subgroups.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Etanol / Metanfetamina Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Adolescent / Humans País/Região como assunto: Oceania Idioma: En Revista: J Psychopharmacol Assunto da revista: PSICOFARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Nova Zelândia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Etanol / Metanfetamina Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Adolescent / Humans País/Região como assunto: Oceania Idioma: En Revista: J Psychopharmacol Assunto da revista: PSICOFARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Nova Zelândia